| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-13 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.32 | 9e-10 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |